癌症恶病质
Cancer cachexia.
作者信息
Dhanapal Raghu, Saraswathi Tr, Govind Rajkumar N
机构信息
Department of Oral Pathology, Vishnu Dental College, Bhimavaram, Andhra Pradesh, India.
出版信息
J Oral Maxillofac Pathol. 2011 Sep;15(3):257-60. doi: 10.4103/0973-029X.86670.
Abstract
Cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia and anemia. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors. The signs and symptoms of cachexia are considered as the prognostic parameters in cancer patients. This review gives an emphasis on the various mechanisms involved in cachexia and an insight into head and neck cancer cachexia.
摘要
癌症恶病质是一种以体重减轻、厌食、乏力和贫血为特征的消耗综合征。由于肿瘤和宿主因素的复杂相互作用，该综合征的发病机制是多因素的。恶病质的体征和症状被视为癌症患者的预后参数。本综述重点介绍了恶病质涉及的各种机制，并深入探讨了头颈癌恶病质。
相似文献
1
Cancer cachexia.
J Oral Maxillofac Pathol. 2011 Sep;15(3):257-60. doi: 10.4103/0973-029X.86670.
2
Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia.
J Cachexia Sarcopenia Muscle. 2020 Jun;11(3):619-635. doi: 10.1002/jcsm.12528. Epub 2020 Mar 6.
3
Understanding Cachexia in Head and Neck Cancer.
Asia Pac J Oncol Nurs. 2021 Aug 27;8(5):527-538. doi: 10.4103/apjon.apjon-2145. eCollection 2021 Sep-Oct.
4
Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia.
Int J Biochem Cell Biol. 2005 May;37(5):1084-104. doi: 10.1016/j.biocel.2004.10.003. Epub 2004 Dec 30.
5
Cytokines and cancer anorexia cachexia syndrome.
Am J Hosp Palliat Care. 2008 Oct-Nov;25(5):407-11. doi: 10.1177/1049909108315518. Epub 2008 Apr 10.
6
Cancer cachexia syndrome in head and neck cancer patients: Part II. Pathophysiology.
Head Neck. 2007 May;29(5):497-507. doi: 10.1002/hed.20630.
7
Cancer anorexia - cachexia syndrome.
Acta Med Indones. 2012 Apr;44(2):154-62.
8
Muscle wasting in cancer and ageing: cachexia versus sarcopenia.
Adv Gerontol. 2006;18:39-54.
9
[The cachexia-anorexia syndrome among oncological patients].
Gac Med Mex. 2008 Sep-Oct;144(5):435-40.
10
[Pathogenesis and treatment of cancer anorexia-cachexia, with special emphasis on aged patients].
Nihon Ronen Igakkai Zasshi. 2004 Sep;41(5):460-7. doi: 10.3143/geriatrics.41.460.
引用本文的文献
1
Vagal blockade of the brain-liver axis deters cancer-associated cachexia.
Cell. 2025 Jul 29. doi: 10.1016/j.cell.2025.07.016.
2
Intramuscular CMT-167 Tumors Produce a Mild Cachexia Phenotype in C57BL/6J Mice.
JCSM Commun. 2025 Jan-Jun;8(1). doi: 10.1002/rco2.117. Epub 2025 Feb 6.
3
Exploring the Chemopreventive and Antioxidant Effects of Spearmint Leaf Hydroethanolic Extract in HPV16-transgenic Mice.
In Vivo. 2025 May-Jun;39(3):1303-1313. doi: 10.21873/invivo.13934.
4
Metabolic interplays between the tumour and the host shape the tumour macroenvironment.
Nat Rev Cancer. 2025 Apr;25(4):274-292. doi: 10.1038/s41568-024-00786-4. Epub 2025 Jan 20.
5
Cell-death induced immune response and coagulopathy promote cachexia in .
bioRxiv. 2025 Feb 10:2025.01.07.631515. doi: 10.1101/2025.01.07.631515.
6
Updates on Methods for Body Composition Analysis: Implications for Clinical Practice.
Curr Obes Rep. 2025 Jan 11;14(1):8. doi: 10.1007/s13679-024-00593-w.
7
The association between behavioral habits and physical health status in prostate cancer patients: a large US national health-related survey.
Prostate Int. 2024 Dec;12(4):207-212. doi: 10.1016/j.prnil.2024.08.001. Epub 2024 Aug 17.
8
Sarcopenia's Role in Neoadjuvant Chemotherapy Outcomes for Locally Advanced Breast Cancer: A Retrospective Analysis.
Med Sci Monit. 2024 Nov 26;30:e945240. doi: 10.12659/MSM.945240.
9
Preventing loss of sirt1 lowers mitochondrial oxidative stress and preserves C2C12 myotube diameter in an in vitro model of cancer cachexia.
Physiol Rep. 2024 Jul;12(13):e16103. doi: 10.14814/phy2.16103.
10
Brassinin alleviates cancer cachexia by suppressing diverse inflammatory mechanisms in mice.
MedComm (2020). 2024 May 28;5(6):e558. doi: 10.1002/mco2.558. eCollection 2024 Jun.
本文引用的文献
1
Cancer cachexia therapy: a key weapon in the fight against cancer.
Curr Opin Clin Nutr Metab Care. 2011 May;14(3):268-73. doi: 10.1097/MCO.0b013e3283455e21.
2
Hormonal regulators of appetite.
Int J Pediatr Endocrinol. 2009;2009:141753. doi: 10.1155/2009/141753. Epub 2008 Dec 3.
3
Mechanisms of cancer cachexia.
Physiol Rev. 2009 Apr;89(2):381-410. doi: 10.1152/physrev.00016.2008.
4
Refeeding syndrome--awareness, prevention and management.
Head Neck Oncol. 2009 Jan 26;1:4. doi: 10.1186/1758-3284-1-4.
5
Inflammatory burden and amino acid metabolism in cancer cachexia.
Curr Opin Clin Nutr Metab Care. 2009 Jan;12(1):72-7. doi: 10.1097/MCO.0b013e32831cef61.
6
Defining cancer cachexia in head and neck squamous cell carcinoma.
Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6561-7. doi: 10.1158/1078-0432.CCR-07-0116.
7
Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis.
Am J Clin Nutr. 2006 Jun;83(6):1345-50. doi: 10.1093/ajcn/83.6.1345.
8
Mediators involved in the cancer anorexia-cachexia syndrome: past, present, and future.
Nutrition. 2005 Sep;21(9):977-85. doi: 10.1016/j.nut.2005.02.003.
9
Cancer anorexia-cachexia syndrome: cytokines and neuropeptides.
Curr Opin Clin Nutr Metab Care. 2004 Jul;7(4):427-34. doi: 10.1097/01.mco.0000134363.53782.cb.
10
Muscle UCP-3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans.
Br J Cancer. 2002 Feb 1;86(3):372-5. doi: 10.1038/sj.bjc.6600074.
Zotero 插件